Guizhou Chanhen Chemical Corporation
SZSE:002895.SZ
18.36 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,905.647 | 4,319.508 | 3,447.465 | 2,530.099 | 1,777.252 | 1,749.308 | 1,290.277 | 1,183.78 | 1,085.362 | 1,103.34 | 845.476 | 796.256 |
| Cost of Revenue
| 3,949.255 | 2,676.416 | 1,898.371 | 1,812.302 | 1,339.861 | 1,271.455 | 1,017.745 | 880.338 | 782.841 | 827.989 | 662.426 | 701.183 |
| Gross Profit
| 1,956.392 | 1,643.092 | 1,549.095 | 717.798 | 437.391 | 477.852 | 272.531 | 303.442 | 302.521 | 275.351 | 183.05 | 95.073 |
| Gross Profit Ratio
| 0.331 | 0.38 | 0.449 | 0.284 | 0.246 | 0.273 | 0.211 | 0.256 | 0.279 | 0.25 | 0.217 | 0.119 |
| Reseach & Development Expenses
| 138.903 | 101.118 | 110.088 | 38.709 | 32.585 | 32.58 | 16.419 | 17.462 | 12.942 | 8.626 | 5.37 | 0 |
| General & Administrative Expenses
| 78.115 | 94.788 | 49.345 | 30.715 | 16.452 | 12.503 | 10.832 | 11.097 | 16.044 | 11.898 | 12.542 | 38.213 |
| Selling & Marketing Expenses
| 74.391 | 53.481 | 59.052 | 40.349 | 109.589 | 128.214 | 96.306 | 84.615 | 82.846 | 72.386 | 58.398 | 36.899 |
| SG&A
| 152.506 | 148.269 | 108.397 | 71.064 | 126.041 | 140.717 | 107.138 | 95.712 | 98.889 | 84.285 | 70.94 | 75.112 |
| Other Expenses
| 473.199 | 267.619 | 249.209 | 131.741 | 91.357 | 64.571 | -0.832 | -1.142 | -3.509 | 3.744 | -0.984 | -4.071 |
| Operating Expenses
| 764.608 | 671.858 | 467.694 | 241.514 | 249.983 | 237.868 | 173.585 | 148.548 | 151.7 | 126.474 | 102.584 | 76.375 |
| Operating Income
| 1,191.784 | 971.235 | 969.209 | 438.38 | 178.842 | 226.353 | 98.228 | 158.738 | 147.982 | 141.732 | 64.717 | 1,268.781 |
| Operating Income Ratio
| 0.202 | 0.225 | 0.281 | 0.173 | 0.101 | 0.129 | 0.076 | 0.134 | 0.136 | 0.128 | 0.077 | 1.593 |
| Total Other Income Expenses Net
| -18.773 | -5.356 | -24.595 | -2.475 | -1.571 | -5.502 | -0.832 | -1.184 | -4.183 | 2.294 | -3.559 | -4.077 |
| Income Before Tax
| 1,173.011 | 965.879 | 944.614 | 435.905 | 177.271 | 220.851 | 97.395 | 157.595 | 143.311 | 144.026 | 61.158 | 1,264.705 |
| Income Before Tax Ratio
| 0.199 | 0.224 | 0.274 | 0.172 | 0.1 | 0.126 | 0.075 | 0.133 | 0.132 | 0.131 | 0.072 | 1.588 |
| Income Tax Expense
| 214.99 | 176.988 | 156.053 | 51.344 | 34.09 | 41.4 | 20.744 | 24.182 | 20.977 | 26.686 | 9.31 | 189.136 |
| Net Income
| 956.481 | 766.404 | 758.662 | 367.765 | 142.613 | 180.401 | 77.215 | 133.414 | 122.334 | 117.341 | 51.848 | 1,076.279 |
| Net Income Ratio
| 0.162 | 0.177 | 0.22 | 0.145 | 0.08 | 0.103 | 0.06 | 0.113 | 0.113 | 0.106 | 0.061 | 1.352 |
| EPS
| 1.79 | 1.53 | 1.55 | 0.76 | 0.34 | 0.45 | 0.19 | 0.36 | 0.34 | 0.33 | 0.15 | 2.99 |
| EPS Diluted
| 1.69 | 1.52 | 1.48 | 0.75 | 0.33 | 0.44 | 0.19 | 0.36 | 0.34 | 0.33 | 0.15 | 2.99 |
| EBITDA
| 1,718.523 | 1,425.008 | 1,236.396 | 591.071 | 264.708 | 302.701 | 163.949 | 212.992 | 208.088 | 208.792 | 117.872 | 69.161 |
| EBITDA Ratio
| 0.291 | 0.33 | 0.359 | 0.234 | 0.149 | 0.173 | 0.127 | 0.18 | 0.192 | 0.189 | 0.139 | 0.087 |